United States

Chemokine Therapeutics Corp (CTI)

Track

Track

Ticker: CTI
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Salari Hassan Large shareholder
Transaction date
Purchase
Price
325.58
Quantity 73,687 -12.1%
Value US$1,548,429
Salari Hassan Large shareholder
Transaction date
Purchase
Price
261.25
Quantity 84,119 +38.9%
Value US$163,058
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Sale
Price
487.76
Quantity 6,471 -0.2%
Value US$3,216,082
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Sale
Price
0.10
Quantity 9,200 -13.4%
Value US$920
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Sale
Price
0.10
Quantity 10,000 -12.7%
Value US$1,000
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Sale
Price
0.11
Quantity 1,450 -1.8%
Value US$160
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Purchase
Price
0.07
Quantity 25,000 +45.5%
Value US$1,625
Evans Donald RM V.P. Corporate Communications Officer
Transaction date
Purchase
Price
0.09
Quantity 30,000 +120.0%
Value US$2,550
Kowalchuk George M Non-Executive Director
Transaction date
Purchase
Price
0.15
Quantity 666,666 +432.0%
Value US$100,000
Salari Hassan Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.15
Quantity 80,000 +inf%
Value US$12,000
Salari Hassan Chief Scientific Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.18
Quantity 50,000 +0.8%
Value US$9,000
Salari Hassan Pres./Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
0.16
Quantity 50,000 +0.8%
Value US$8,000
Byrd Bernard C II Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 300,000 +42.9%
Value US$60,000
Bahadori Reza Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 300,000 +202.0%
Value US$60,000
Korz Walter Vice President, Drug Dev. Officer
Transaction date
Purchase
Price
0.20
Quantity 50,000 +inf%
Value US$10,000
Salari Hassan Pres./Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
0.20
Quantity 312,500 +5.0%
Value US$62,500
JAFFER BASHIR Chief Financial Officer Executive Director
Transaction date
Purchase
Price
0.20
Quantity 50,000 +inf%
Value US$10,000
Kuhn Brian Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 300,000 +56.9%
Value US$60,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-08-29 2008-08-27 B Purchase Salari Hassan Large shareholder
73,687 -12.1%
325.58
US$1,548,429 		73,687 -12.1% 325.58 US$1,548,429
2008-08-29 2008-08-27 B Purchase Salari Hassan Large shareholder
84,119 +38.9%
261.25
US$163,058 		84,119 +38.9% 261.25 US$163,058
2008-08-27 2008-08-25 S Sale Evans Donald RM

V.P. Corporate Communications

Officer
6,471 -0.2%
487.76
US$3,216,082 		6,471 -0.2% 487.76 US$3,216,082
2008-08-27 2008-08-25 S Sale Evans Donald RM

V.P. Corporate Communications

Officer
9,200 -13.4%
0.10
US$920 		9,200 -13.4% 0.10 US$920
2008-08-27 2008-08-25 S Sale Evans Donald RM

V.P. Corporate Communications

Officer
10,000 -12.7%
0.10
US$1,000 		10,000 -12.7% 0.10 US$1,000
2008-08-27 2008-08-22 S Sale Evans Donald RM

V.P. Corporate Communications

Officer
1,450 -1.8%
0.11
US$160 		1,450 -1.8% 0.11 US$160
2008-08-27 2008-08-22 B Purchase Evans Donald RM

V.P. Corporate Communications

Officer
25,000 +45.5%
0.07
US$1,625 		25,000 +45.5% 0.07 US$1,625
2008-08-27 2008-08-22 B Purchase Evans Donald RM

V.P. Corporate Communications

Officer
30,000 +120.0%
0.09
US$2,550 		30,000 +120.0% 0.09 US$2,550
2008-06-17 2008-06-13 B Purchase Kowalchuk George M Non-Executive Director
666,666 +432.0%
0.15
US$100,000 		666,666 +432.0% 0.15 US$100,000
2008-06-17 2008-06-13 B Purchase Salari Hassan

Chief Scientific Officer

Executive Director Large shareholder
80,000 +inf%
0.15
US$12,000 		80,000 +inf% 0.15 US$12,000
2008-04-17 2008-04-16 B Purchase Salari Hassan

Chief Scientific Officer

Executive Director Large shareholder
50,000 +0.8%
0.18
US$9,000 		50,000 +0.8% 0.18 US$9,000
2008-04-11 2008-04-10 B Purchase Salari Hassan

Pres./Chief Scientific Officer

Executive Director
50,000 +0.8%
0.16
US$8,000 		50,000 +0.8% 0.16 US$8,000
2008-02-08 2008-02-07 B Purchase Byrd Bernard C II Non-Executive Director
300,000 +42.9%
0.20
US$60,000 		300,000 +42.9% 0.20 US$60,000
2008-02-08 2008-02-07 B Purchase Bahadori Reza Non-Executive Director
300,000 +202.0%
0.20
US$60,000 		300,000 +202.0% 0.20 US$60,000
2008-02-08 2008-02-07 B Purchase Korz Walter

Vice President, Drug Dev.

Officer
50,000 +inf%
0.20
US$10,000 		50,000 +inf% 0.20 US$10,000
2008-02-08 2008-02-07 B Purchase Salari Hassan

Pres./Chief Scientific Officer

Executive Director
312,500 +5.0%
0.20
US$62,500 		312,500 +5.0% 0.20 US$62,500
2008-02-08 2008-02-07 B Purchase JAFFER BASHIR

Chief Financial Officer

Executive Director
50,000 +inf%
0.20
US$10,000 		50,000 +inf% 0.20 US$10,000
2008-02-08 2008-02-07 B Purchase Kuhn Brian Non-Executive Director
300,000 +56.9%
0.20
US$60,000 		300,000 +56.9% 0.20 US$60,000
Explore more

More insider trading research around Chemokine Therapeutics Corp

More insider trades in United States
Insider trading in North America